Inventor · disambiguated record
Jamila Louahed
Also filed as: LOUAHED JAMILA
6 granted patents·11 pending applications·34 citations·filing 1999–2012
80Inventor score
Top patents by PatentIndex Score
17 records- 0189US7972833B2Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereofWYETH LLC·Filed 2007·Granted Jul 5, 2011·10 cites·10 claims
- 0288US8309096B2Fusion proteinBLAIS NORMAND·Filed 2009·Granted Nov 13, 2012·11 cites·5 claims
- 0369US6716603B2Nucleic acids encoding a chloride channel proteinGENAERA CORP·Filed 2002·Granted Apr 6, 2004·3 cites·18 claims
- 0462US7919248B2Methods for the modulation of IL-13LIGAND PHARM INC·Filed 2008·Granted Apr 5, 2011·0 cites·12 claims
- 0559US2009068185A1Asthma associated factors as targets for treating atopic allergies including asthma and related disordersHOLROYD KENNETH J·Filed 2007·Application pending·0 cites
- 0656US7211254B2Methods for treating ICACC protein associated diseasesGENAERA CORP·Filed 2004·Granted May 1, 2007·0 cites·12 claims
- 0756US6576434B1Methods for identification of agents which modulate chloride channel activityGENAERA CORP·Filed 1999·Granted Jun 10, 2003·10 cites·32 claims
- 0856US2010008980A1Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of CancerBRICHARD VINCENT·Filed 2008·Application pending·0 cites
- 0956US2004110189A1Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereofFiled 2003·Application pending·0 cites
- 1053US2004219149A1Methods for the modulation of il-13Filed 2002·Application pending·0 cites
- 1145US2008096981A1Antibodies against inducible TH2 cell factorsGENAERA CORP·Filed 2006·Application pending·0 cites
- 1242US2003166150A1Asthma associated factors as targets for treating atopic allergies including asthma and related disordersLUDWIG INST CANCER RES·Filed 2003·Application pending·0 cites
- 1342US2015147350A1Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK InhibitorGLAXOSMITHKLINE LLC·Filed 2012·Application pending·0 cites
- 1441US2010247580A1Method for Classifying Cancer Patients as Responder or Non-Responder to ImmunotherapyCOCHE THIERRY·Filed 2008·Application pending·0 cites
- 1540US2002156013A1Asthma associated factors as targets for treating atopic allergies including asthma and related disordersFiled 2002·Application pending·0 cites
- 1636US2011070268A1MethodGLAXOSMITHKLINE BIOLOG SA·Filed 2010·Application pending·0 cites
- 1735US2010021424A1Method For Identifying Whether A Patient Will Be Responder or Not to ImmunotherapyBRICHARD VINCENT·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jamila Louahed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →